» Articles » PMID: 35816791

Drug Use Behaviors, Trauma, and Emotional Affect Following the Overdose of a Social Network Member: A Qualitative Investigation

Overview
Publisher Elsevier
Date 2022 Jul 11
PMID 35816791
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Scant research has examined the influence of overdoses occurring in social networks (i.e., knowing someone who has overdosed) on individual overdose risk. We sought to characterize drug use behaviors of individuals following the overdose of someone in their social network.

Methods: We conducted semi-structured interviews with 25 people who use drugs and knew someone who overdosed in the prior 90 days. All interviews were conducted in person in Rhode Island from July to October 2021. Data were stratified by drug use behaviors following the overdose of a network member (i.e., risk behaviors, protective behaviors, no change; selected a priori) and analyzed using a thematic analysis variation to identify salient themes.

Results: We identified variation in the effect of knowing someone who overdosed on subsequent drug use behaviors and emotional affect. Several participants described increasing their drug use or using more types of drugs than usual to manage feelings of bereavement and trauma, and a subset of these participants described increased drug use with suicidal intention and increased suicidal ideations following the overdose event. Other participants described reducing their drug use and engaging in protective behaviors in response to heightened perceived overdose risk, protection motivation (i.e., increased motivation to protect oneself), and concern for others. Additionally, some participants reported no change in drug use behaviors, and these participants described already engaging in harm reduction practices, feeling desensitized due to frequent or repeated exposure to overdose, and ambivalence about living.

Conclusions: Findings suggest a need for enhanced investment in network-based overdose prevention interventions, as well as more robust integration of bereavement support and mental health services in settings that serve people who use drugs. The findings also suggest a need for future research to identify mediators of the effect of overdose occurring in social networks on individual overdose risk.

Citing Articles

Exploring the Psychological Side of Fentanyl: A Scoping Review to Disclose the Psychosocial Dimensions of Illicitly Manufactured Fentanyl Users.

Caponnetto P, Triscari S, Prezzavento G, Farrugio G, Farrauto C, Lanzafame S Health Psychol Res. 2024; 12:120958.

PMID: 39624107 PMC: 11610925. DOI: 10.52965/001c.120958.


Measuring network dynamics of opioid overdose deaths in the United States.

Tiwari K, Rahimian M, Roberts M, Kumar P, Buchanich J Sci Rep. 2024; 14(1):29563.

PMID: 39609532 PMC: 11604951. DOI: 10.1038/s41598-024-80627-4.


"Catching Chain" With Medicaid: The Impact of Medicaid Access on Opioid Overdose Mortality in Adults Released From State Detention.

Blumberger L, Calo W, Mallinson D, Liu G, Leslie D Psychiatr Res Clin Pract. 2024; 6(3):94-103.

PMID: 39568500 PMC: 11574460. DOI: 10.1176/appi.prcp.20230080.


Psychosocial factors associated with overdose subsequent to Illicit Drug use: a systematic review and narrative synthesis.

Byrne C, Sani F, Thain D, Fletcher E, Malaguti A Harm Reduct J. 2024; 21(1):81.

PMID: 38622647 PMC: 11017611. DOI: 10.1186/s12954-024-00999-8.


Exploring trauma and wellbeing of people who use drugs after witnessing overdose: A qualitative study.

Song M, Desai I, Meyer A, Shah H, Saloner B, Sherman S Int J Drug Policy. 2023; 122:104239.

PMID: 37890394 PMC: 11811910. DOI: 10.1016/j.drugpo.2023.104239.


References
1.
Kerensky T, Walley A . Opioid overdose prevention and naloxone rescue kits: what we know and what we don't know. Addict Sci Clin Pract. 2017; 12(1):4. PMC: 5219773. DOI: 10.1186/s13722-016-0068-3. View

2.
McDonald R, Strang J . Are take-home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria. Addiction. 2016; 111(7):1177-87. PMC: 5071734. DOI: 10.1111/add.13326. View

3.
Feigelman W, Jordan J, Gorman B . Parental grief after a child's drug death compared to other death causes: investigating a greatly neglected bereavement population. Omega (Westport). 2011; 63(4):291-316. DOI: 10.2190/OM.63.4.a. View

4.
Van Zee A . The promotion and marketing of oxycontin: commercial triumph, public health tragedy. Am J Public Health. 2008; 99(2):221-7. PMC: 2622774. DOI: 10.2105/AJPH.2007.131714. View

5.
Rudolph A, Young A, Havens J . Using Network and Spatial Data to Better Target Overdose Prevention Strategies in Rural Appalachia. J Urban Health. 2018; 96(1):27-37. PMC: 6391296. DOI: 10.1007/s11524-018-00328-y. View